Drug research: myths, hype and reality
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Drug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Kelder, J., Grootenhuis, P. D. J., Bayada, D. M., Delbressine, L. P. C., & Ploemen, J.-P. (1999) · Pharmaceutical Research · doi:10.1023/a:1015040217741 · Cited by 813
Research works printed but not linked: 1
- Watson, J. D., with Berry, A. DNA. The Secret of Life. (William Heinemann, London, 2003).
Cited by
Items 201–300 of 353
Chiral Drug Discovery and Development – From Concept Stage to Market Launch
Federsel, H. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00054-7 · Cited by 11
García‐Sosa, A. T., Oja, M., Hetényi, C., & Maran, U. (2012) · Molecular Informatics · doi:10.1002/minf.201100094 · Cited by 11
Collection and preparation of molecular databases for virtual screening
Saxena, S. K., & Prathipati, P. (2006) · SAR and QSAR in environmental research · doi:10.1080/10629360600884462 · Cited by 10
Early Repositioning Through Compound Set Enrichment Analysis: A Knowledge-Recycling Strategy
Temesi, G., Bolgár, B., Arany, Á., Szalai, C., Antal, P., & Mátyus, P. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.4 · Cited by 12
Predicting Target and Chemical Druggability
Oprea, T. I., & Hasselgren, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12342-x · Cited by 12
Network Intervention, a Method to Address Complex Therapeutic Strategies
Zhang, C., Zhou, W., Guan, D.-G., Wang, Y., & Lü, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00754 · Cited by 12
Hassaneen, H. M., Saleh, F. M., Abdallah, T. A., Mohamed, M. F., Mohamed, Y. S., Awad, E. M., & Abdelhamid, I. A. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666181017162459 · Cited by 10
Pereira, V. S. D. S., Emery, F. D. S., Lobo, L., Nogueira, F., Oliveira, J. I. N., Fulco, U. L., Albuquerque, E. L., Katzin, A. M., & de Andrade‐Neto, V. F. (2018) · Malaria Journal · doi:10.1186/s12936-018-2615-8 · Cited by 10
The Intersection of Strategy and Drug Research
Moos, W. H. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00033-x · Cited by 14
Computational Docking as a Tool for the Rational Design of Carbohydrate-Based Drugs
Frank, M. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_42 · Cited by 10
The eradication of leprosy: molecular modeling techniques for novel drug discovery
Anusuya, S., & Natarajan, J. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.826188 · Cited by 12
Transforming drug discovery: the impact of AI and molecular simulation on R&D efficiency
Iwata, H. (2024) · Bioanalysis · doi:10.1080/17576180.2024.2437283 · Cited by 11
On some recent insights in Integral Biomathics
Simeonov, P. L., Gómez‐Ramírez, J., & Siregar, P. (2013) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2013.06.001 · Cited by 12
Pramanik, S., Kutzner, A., & Heese, K. (2015) · Molecular Informatics · doi:10.1002/minf.201500035 · Cited by 9
Oyarzábal, J., Pastor, J., & Howe, T. J. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900308u · Cited by 9
A Prospective Method To Guide Small Molecule Drug Design
Johnson, A. T. (2014) · Journal of Chemical Education · doi:10.1021/ed5002653 · Cited by 9
Regenmortel, M. H. V. V. (2019) · Springer eBooks · doi:10.1007/978-3-030-32459-9_6 · Cited by 10
Utilizing a cell-free protein synthesis platform for the biosynthesis of a natural product, caffeine
Ditzel, A., Zhao, F., Gao, X., & Phillips, G. N. (2023) · Synthetic Biology · doi:10.1093/synbio/ysad017 · Cited by 10
Obi, P., GC, J. B., Mariasoosai, C., Diyaolu, A., & Natesan, S. (2024) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.4c00315 · Cited by 8
History of 3D pharmacophore searching: commercial, academic and open-source tools
Drie, J. H. V. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.12.002 · Cited by 8
Natesan, S., Wang, T., Lukáčová, V., Bartus, V., Khandelwal, A., & Baláž, Š. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200055s · Cited by 8
Novel Therapies in Childhood Heart Failure: Today and Tomorrow
Penny, D. J., & Vick, G. W. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.06.003 · Cited by 8
Automated and enabling technologies for medicinal chemistry
Nichols, P. L. (2021) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2021.01.003 · Cited by 10
Emery, A. C. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00016-6 · Cited by 8
Docking and Scoring for Structure‐based Drug Design
Rarey, M., Degen, J., & Reulecke, I. (2007) · Wiley eBooks · doi:10.1002/9783527619368.ch16 · Cited by 9
Computational Aids for Assessing Bioactivities
Wolfram, E., & Trifan, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812364-5.00010-9 · Cited by 10
Kenakin, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813957-8.00011-4 · Cited by 8
Atom Environment Kernels on Molecules
Yamashita, H., Higuchi, T., & Yoshida, R. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400403w · Cited by 9
The Why and How of Absorption, Distribution, Metabolism, Excretion, and Toxicity Research
Waterbeemd, H. V. D., & Testa, B. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00116-4 · Cited by 8
Virtual Screening in Drug Discovery
McGregor, M. J., Luo, Z., & Jiang, X. (2006) · Wiley eBooks · doi:10.1002/9780470131862.ch3 · Cited by 8
Pipeline Impact of Radiolabeled Compounds in Drug Discovery and Development
Srirajan, V., & Reed, A. D. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.2c00281 · Cited by 6
Imming, P. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374194-3.00002-0 · Cited by 6
Structure-Based Drug Design – A Historical Perspective and the Future
Abraham, D. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00243-1 · Cited by 7
Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors
Yousuf, M. (2019) · Current Cancer Drug Targets · doi:10.2174/1568009619666190320102238 · Cited by 6
Kraft, A. (2013) · Pan Stanford Publishing eBooks · doi:10.1201/b14790-5 · Cited by 18
9.07 High-Throughput Purification in Support of Pharmaceutical Discovery
McClain, R. T., & Streckfuss, E. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-08-097742-3.00918-6 · Cited by 6
Kenakin, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407663-1.00011-9 · Cited by 6
Williams, M. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00056-0 · Cited by 6
Peláez, R., López‐Pérez, J. L., & Medarde, M. (2007) · Advances in intelligent and soft computing · doi:10.1007/978-3-540-74972-1_53 · Cited by 6
Antiparasitic Activity of Coumarin–Chalcone (3‐Cinnamoyl‐2 H ‐Chromen‐2‐Ones) Hybrids
Valencia, S., Quiñones, W., Robledo, S. M., Marín-Loaiza, J. C., Durango, D., & Gil, J. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402515 · Cited by 5
Polański, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14327-6 · Cited by 8
Firempong, C. K., Cao, X., Tong, S., Yu, J., & Xu, X. (2015) · RSC Advances · doi:10.1039/c5ra08322b · Cited by 6
Ligand-directed profiling: applications to target drug discovery in cancer
Staquicini, F. I., Pasqualini, R., & Arap, W. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460440802628152 · Cited by 5
Graph Traversal Edit Distance and Extensions
Boroojeny, A. E., Shrestha, A., Sharifi‐Zarchi, A., Gallagher, S. R., Şahinalp, S. C., & Chitsaz, H. (2020) · Journal of Computational Biology · doi:10.1089/cmb.2019.0511 · Cited by 5
Blocking the Hype‐Hypocrisy‐Falsification‐Fakery Pathway is Needed to Safeguard Science
Hopf, H., Matlin, S. A., Mehta, G., & Krief, A. (2019) · Angewandte Chemie · doi:10.1002/ange.201911889 · Cited by 5
Computational and Pharmacoinformatic Approaches to Oral Bioavailability Prediction
Cabrera‐Pérez, M. Á., & González‐Álvarez, I. (2011) · Wiley eBooks · doi:10.1002/9781118067598.ch33 · Cited by 5
Tsaioun, K., & Kates, S. A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9530-8_30 · Cited by 6
Genomics-based drug innovation: visions and commercial viability
Kraft, A., & Rothman, H. (2008) · International Journal of Biotechnology · doi:10.1504/ijbt.2008.021309 · Cited by 4
Fukushima, M. (2016) · Science & Technology Studies · doi:10.23987/sts.55929 · Cited by 6
Kraft, A. (2013) · doi:10.1201/b14790-6 · Cited by 4
Shahzadi, Z., Abbas, G., & Azam, S. S. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.112939 · Cited by 4
The conductor and his orchestra
Lewi, P. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.02.008 · Cited by 4
Can Cell Systems Biology Rescue Drug Discovery?
Butcher, E. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-31339-7_8 · Cited by 5
Kubinyi, H. (2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt001 · Cited by 4
Self-citationPharmacology in 21st century biomedical research
Mullane, K., Williams, M. J., & Winquist, R. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.10.018 · Cited by 4
Ertl, P. (2012) · doi:10.1002/9783527654307.ch7 · Cited by 4
Quantum kernel method for learning graph data via quantum walk
Cao, L., & Wang, Y. (2025) · Physical Review A · doi:10.1103/k2nx-d649 · Cited by 5
Liao, Y., Wei, Z., Xu, H., Zhang, Z., & Zhu, F. (2024) · Precision medication. · doi:10.1016/j.prmedi.2024.10.002 · Cited by 5
Elguero, J. (2011) · Structural Chemistry · doi:10.1007/s11224-011-9891-z · Cited by 3
Metabophore-mediated retro-metabolic (‘MeMeReMe’) approach in drug design
Balaji, S. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103736 · Cited by 4
New drug discovery and development
da Silva, M. F., dos Santos, A. B. S. F., Batista, V. D. M., Rodrigues, É. E. D. S., de Araújo‐Júnior, J. X., & da Silva‐Júnior, E. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91817-6.00017-6 · Cited by 4
Novel Biomimetic Microphysiological Systems for Tissue Regeneration and Disease Modeling
Budhwani, K. I., Oliver, P. G., Buchsbaum, D. J., & Thomas, V. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0947-2_6 · Cited by 3
Informatics approaches for identifying biologic relationships in time‐series data
McKinney, B. A. (2008) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.12 · Cited by 3
What is Next for Small-Molecule Drug Discovery?
Doweyko, A. M., & Doweyko, L. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.72 · Cited by 6
Peláez, R., Therón, R., García, C. A., López‐Pérez, J. L., & Medarde, M. (2008) · Advances in soft computing · doi:10.1007/978-3-540-85861-4_23 · Cited by 3
Systematic Evaluation of the Efficiencies of Proteins and Chemicals in Pharmaceutical Applications
Hamon, M., & Hong, J. W. (2012) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814405522_0002 · Cited by 3
Structural Chemogenomics Databases to Navigate Protein–Ligand Interaction Space
Kanev, G. K., Kooistra, A. J., de Esch, I. J. P., & de Graaf, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12298-x · Cited by 3
Recent Advancements in Computing Reliable Binding Free Energies in Drug Discovery Projects
Murugan, N. A., Poongavanam, V., & Priyakumar, U. D. (2019) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-030-05282-9_7 · Cited by 3
What to expect from rational drug design
Adam, M. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.6.773 · Cited by 4
Applications of Protein Arrays for Small Molecule Drug Discovery and Characterization
Michaud, G. A., Aelsalcius, M., Zhou, F. X., Papov, V. V., Merkel, J., Murtha, M. T., Predki, P. F., & Schweitzer, B. I. (2006) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2006.10648071 · Cited by 3
Papoian, R., Scherer, A., Saulnier, M., Staedtler, F., Cordier, A., Legay, F., Maurer, G., Staeheli, J., Vonderscher, J., & Chibout, S. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6809-8 · Cited by 3
Bajaj, S. (2006) · Shodhganga · Cited by 5
3D-Pharma: uma ferramenta para triagem virtual baseada em fingerprints de farmacóforos
Domingues, B. F. (2012) · Americanae (AECID Library) · Cited by 3
The role of drug metabolism in drug discovery and development : case ospemifene
Uusitalo, J. (2015) · Cited by 2
Drug discovery: Chaos can be your friend or your enemy
Miller, S. M., Moos, W. H., Munk, B. H., Munk, S. A., Hart, C. P., & Spellmeyer, D. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824304-6.00012-2 · Cited by 4
Oyedele, A.-Q. K., Boyenle, I. D., Ogunlana, A. T., Ashiru, M. A., Emmanuel, A. O., & Isaac, A. T. (2022) · Pharmaceutical and Biomedical Research · doi:10.32598/pbr.8.4.1052.1 · Cited by 4
Computational aids for assessing bioactivities in phytochemical and natural products research
Wolfram, E., & Trifan, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16102-5.00005-5 · Cited by 5
AI-Enabled Models in the Restoration of Drug Efficacy and Drug Design
Sampathi, S., & Bhatia, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-2596-0_5 · Cited by 2
GTED: Graph Traversal Edit Distance
Boroojeny, A. E., Shrestha, A., Sharifi‐Zarchi, A., Gallagher, S. R., Şahinalp, S. C., & Chitsaz, H. (2018) · Lecture notes in computer science · doi:10.1007/978-3-319-89929-9_3 · Cited by 3
Giordani, F., Buschini, A., Baliani, A., Kaiser, M., Brun, R., Barrett, M. P., Pellacani, C., Poli, P., & Gilbert, I. H. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01449-13 · Cited by 2
Multi-Level Complexities in Technological Development: Competing Strategies for Drug Discovery
Adam, M. (2010) · Boston studies in the philosophy of science · doi:10.1007/978-90-481-9051-5_5 · Cited by 3
The Chemical Genetic Approach: The Interrogation of Biological Mechanisms with Small Molecule Probes
Fisher, M., & Nelson, A. S. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732178-00001 · Cited by 2
Miller, S. M., Moos, W. H., Munk, B. H., & Munk, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100625-2.00010-6 · Cited by 3
The Why and How of Absorption, Distribution, Metabolism, Excretion, and Toxicity Research
Waterbeemd, H. V. D., & Testa, B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.02586-5 · Cited by 2
Harnessing Computational Modeling for Efficient Drug Design Strategies
Singh, K., Bhushan, B., Dube, A. K., Jha, A. K., Rani, K., Mishra, A. K., & Porwal, P. (2024) · Letters in Organic Chemistry · doi:10.2174/0115701786267754231114064015 · Cited by 2
From East to West: A Japanese Pharma perspective on establishing a global research capability
Takatani, M., Kenny, B. A., & Hird, N. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.010 · Cited by 2
Palmer, D. S., & Fedorov, M. V. (2016) · doi:10.1002/9781118700686.ch11 · Cited by 2
Compound Attrition in Phase II/III
Alex, A., Harris, C., Keighley, W. W., & Smith, D. A. (2015) · doi:10.1002/9781118819586.ch4 · Cited by 2
Regulatory and Health Technology Assessment of ATMPs in the European Union: Towards Patient Access
Bloem, L. T., Fabriek, B. O., Schiel, A. E., & ten Ham, R. M. T. (2026) · Springer handbooks · doi:10.1007/978-3-032-01636-2_30 · Cited by 1
Can pharmacoeconomics and ethics be balanced in drug research and development?
Preziosi, P. (2006) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.1.6.513 · Cited by 1
Virtual Ligand Screening for Structure-based Drug Design: Approaches and Progress
Spérandio, O., Miteva, M. A., & Villoutreix, B. O. (2007) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
Le processus de découverte du médicament dans l'industrie pharmaceutique
Scatton, B. (2009) · Journal de la Société de Biologie · doi:10.1051/jbio:2009030 · Cited by 4
Optimal Assignment Kernels for ADME in Silico Prediction
Fröhlich, H. (2010) · IGI Global eBooks · doi:10.4018/978-1-61520-911-8.ch002 · Cited by 1
Oral drug-likeness criteria in preclinical species
Wenlock, M. C. (2016) · MedChemComm · doi:10.1039/c6md00362a · Cited by 1
Miller, S. M., Moos, W. H., Munk, B. H., & Munk, S. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100625-2.00011-8 · Cited by 1
Lead Discovery Using Virtual Screening
Bikker, J. A., & Narasimhan, L. S. (2009) · Topics in medicinal chemistry · doi:10.1007/7355_2009_3 · Cited by 1
De-Risking Drug Discovery Programmes Early with ADMET
Tsaioun, K., & Steven, A. (2011) · InTech eBooks · doi:10.5772/27764 · Cited by 1
Drug Design for Chagas'Disease: Advances and Challenges
Ferreira, E. I. (2012) · Revista Virtual de Química · doi:10.5935/1984-6835.20120019 · Cited by 1
de Oliveira, D. A. B., & Niculau, E. D. S. (2021) · Eclética Química · doi:10.26850/1678-4618eqj.v46.3.2021.p17-32 · Cited by 1
Drug targets and drug-target molecules
Kenakin, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99289-3.00011-7 · Cited by 1
Metadata
- Authors
- Kubinyi, H.
- Corresponding author
- Kubinyi, Hugo
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-08
- Volume
- 2
- Issue
- 8
- Pages
- 665-668
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1487233798
- Cited by
- 348
- References
- 32
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 13 · 2023: 6 · 2022: 9 · 2021: 4 · 2020: 9 · 2019: 16 · 2018: 24 · 2017: 8 · 2016: 15 · 2015: 17 · 2014: 16 · 2013: 17 · 2012: 26
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Characterization of Heterocyclic Compounds
- Keywords
- drug discovery, lead-like compounds, drug-like molecules, oral bioavailability, combinatorial chemistry, high-throughput screening, ADME, computer-aided drug design, structure-based drug design, lead optimization, medicinal chemistry
- MeSH terms
- Chemistry, Pharmaceutical, Humans, Pharmacokinetics, Pharmacology, Research, Technology, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.